Related Experiment Video
Updated: Feb 26, 2026
07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
86.5K
Hypoxia: Signaling the Metastatic Cascade.
Erinn B Rankin1, Jin-Min Nam2, Amato J Giaccia3
1Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5152, USA; Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, CA 94305-5152, USA.
Trends in Cancer
|July 26, 2017
Summary
Hypoxia, or low oxygen, drives tumor metastasis through various cellular processes. Understanding hypoxia-inducible factor (HIF) signaling offers new therapeutic targets for preventing and treating cancer spread.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Hypoxia is a critical tumor microenvironment factor.
- Hypoxia-inducible factor (HIF) signaling is implicated in cancer progression.
Purpose of the Study:
- To review the multifaceted role of hypoxia in promoting tumor metastasis.
- To explore how HIF-dependent signaling influences each stage of the metastatic cascade.
Main Methods:
- Literature review of recent studies on hypoxia and metastasis.
- Analysis of molecular mechanisms linking hypoxia to metastatic processes.
Main Results:
- Hypoxia regulates metabolic reprogramming, stem cell phenotype, invasion, angiogenesis, immune suppression, premetastatic niche formation, and intravasation/extravasation.
- HIF signaling is a key mediator of these hypoxia-induced pro-metastatic effects.
- Hypoxia contributes to resistance to apoptosis in cancer cells.
Conclusions:
- Hypoxia and HIF signaling represent novel paradigms in understanding tumor metastasis.
- Targeting hypoxia and HIF pathways offers new therapeutic strategies for metastatic disease prevention and treatment.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
01:24Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
01:19Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
01:41Non-Canonical Wnt Signaling Pathways
8.5K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.5K